Blueprint for mechanistic, data‐rich early phase clinical pharmacology studies in dermatology

por Rissmann, Robert, Moerland, Matthijs, van Doorn, Martijn B.A.
Publicado 2020

Macular arteritis in an HIV-infected patient improving with adherence to antiretroviral therapy

por Boddé, Elisabeth, Damman, Jeffrey, van Doorn, Martijn B.A.
Publicado 2020

Treatment of a refractory allergic reaction to a red tattoo on the lips with methotrexate and Q-switched Nd-Yag laser

por van der Bent, Sebastiaan A.S., van Doorn, Martijn B.A.
Publicado 2022

Cold-induced urticaria associated with type I cryoglobulinemia, successfully treated with rituximab

por Stroet, Leonie C., Hermans, Maud A.W., Maurer, M., van Doorn, Martijn B.A.
Publicado 2021

A randomized controlled trial with a delayed‐type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man

por Saghari, Mahdi, Gal, Pim, Ziagkos, Dimitrios, Burggraaf, Jacobus, Powell, John F., Brennan, Nuala, Rissmann, Robert, van Doorn, Martijn B.A., Moerland, Matthijs
Publicado 2020

Comprehensive, Multimodal Characterization of an Imiquimod‐Induced Human Skin Inflammation Model for Drug Development

por van der Kolk, Tessa, Assil, Salma, Rijneveld, Rianne, Klaassen, Erica S., Feiss, Gary, Florencia, Edwin, Prens, Errol P., Burggraaf, Jacobus, Moerland, Matthijs, Rissmann, Robert, van Doorn, Martijn B.A.
Publicado 2018

Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers

por Niemeyer‐van der Kolk, Tessa, Assil, Salma, Buters, Thomas P., Rijsbergen, Melanie, Klaassen, Erica S., Feiss, Gary, Florencia, Edwin, Prens, Errol P., Burggraaf, Jacobus, van Doorn, Martijn B.A., Rissmann, Robert, Moerland, Matthijs
Publicado 2020

Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)

por Perez-Garcia, Luis Fernando, Röder, Esther, Krijthe, Bouwe P, Kranenburg-van Koppen, Laura JC, van Adrichem, Roxanne, Zirkzee, Els, Griffioen, Pieter H, Peeters, Kris, Lin, Marry, Struys, Eduard A, Jansen, Gerrit, van Doorn, Martijn BA, de Jonge, Robert, Dohle, Gert R, Dolhain, Radboud JEM
Publicado 2023

Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial

por Niemeyer‐van der Kolk, Tessa, van der Wall, Hein, Hogendoorn, Geretta K., Rijneveld, Rianne, Luijten, Sascha, van Alewijk, Dirk C.J.G., van den Munckhof, Ellen H.A., de Kam, Marieke L., Feiss, Gary L., Prens, Errol P., Burggraaf, Jacobus, Rissmann, Robert, van Doorn, Martijn B.A.
Publicado 2020

How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study

por Cherrez-Ojeda, Ivan, Vanegas, Emanuel, Cherrez, Annia, Felix, Miguel, Weller, Karsten, Magerl, Markus, Maurer, Rasmus Robin, Mata, Valeria L., Kasperska-Zajac, Alicja, Sikora, Agnieszka, Fomina, Daria, Kovalkova, Elena, Godse, Kiran, Rao, Nimmagadda Dheeraj, Khoshkhui, Maryam, Rastgoo, Sahar, Criado, Roberta FJ., Abuzakouk, Mohamed, Grandon, Deepa, Van Doorn, Martijn B.A., Oliveira Rodrigues Valle, Solange, De Souza Lima, Eduardo Magalhães, Thomsen, Simon Francis, Ramón, German D., Matos Benavides, Edgar E., Bauer, Andrea, Giménez-Arnau, Ana M., Kocatürk, Emek, Guillet, Carole, Larco, Jose Ignacio, Zhao, Zuo-Tao, Makris, Michael, Ritchie, Carla, Xepapadaki, Paraskevi, Ensina, Luis Felipe, Cherrez, Sofia, Maurer, Marcus
Publicado 2021